Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
Diseases
Year
9 results
-
Focus on Dementia April 2025 – booklet
This booklet provides an overview of the Department of Health and Aged Care’s initiatives and programs to support people living with dementia, their carers and families. -
National Dementia Action Plan 2024–2034
The National Dementia Action Plan 2024–2034 is Australia’s national dementia policy framework. It aims to improve the lives and care of people living with dementia, their carers and families over the next 10 years. -
National Dementia Action Plan Monitoring and Reporting Framework
A framework that outlines how Australian, state and territory governments will monitor and report progress on the 8 high-level actions in the National Dementia Action Plan 2024–2034. -
National Dementia Action Plan Overview
An overview of the National Dementia Action Plan 2024–2034, including a summary and 8 high-level actions. -
Summary of National Dementia Action Plan 2024–2034
A summary of the vision, purpose and actions contained in the National Dementia Action Plan 2024–2034. -
Vaccine Administration Partners Program Panel
This document contains a list of COVID-19 immunisation providers (IProviders) on the Vaccine Administration Partners Program (VAPP) Panel. -
Vaccine Administration Partners Program – Enterprise order request (EOR)
Immunisation providers (IProviders) must provide an Enterprise Order Request to us. The Enterprise Order Request will become an Enterprise Order when we approve it. -
Vaccine Administration Partners Program – Request for quotation template
Immunisation providers (IProviders) in receipt of a Request for Quote (RFQ) wanting to respond must complete and return the RFQ to the requesting Agency as a quotation for the provision of services. -
Panel Head Agreement
IProviders who have been successfully appointed to the panel, must enter into a Panel Head Agreement — a deed between the Commonwealth of Australia, as represented by the Department of Health, and the IProvider for the National Vaccine Administration Partners Program.